hrp0086p1-p138 | Bone & Mineral Metabolism P1 | ESPE2016
Kubota Takuo
, Yamamoto Keiko
, Miyata Kei
, Takeyari Shinji
, Yamamoto Kenichi
, Nakayama Hirofumi
, Fujiwara Makoto
, Kitaoka Taichi
, Takakuwa Satoshi
, Ozono Keiichi
Background: Fibroblast growth factor 23 (FGF23) decreases renal phosphate reabsorption and serum 1,25-dihydroxyvitamin D [1,25(OH)2D] levels. X-linked hypophosphatemic rickets (XLH) is caused by mutations in the PHEX gene and accompanied by decreased serum inorganic phosphate (IP) and elevated serum FGF23 levels. Patients with XLH are generally treated with oral active vitamin D and phosphate, but some previous reports indicated that serum FGF23 levels increased with ...